Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Acromegaly × Radiosurgery × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Brain Neoplasms 118 Carcinoma, Non-Small-Cell Lung 112 Prostatic Neoplasms 101 Neoplasm Metastasis 83 Lung Neoplasms 64 Pancreatic Neoplasms 61 Carcinoma, Hepatocellular 58 Breast Neoplasms 45 Melanoma 43 Carcinoma, Renal Cell 32 Neoplasms 31 Colorectal Neoplasms 24 Glioblastoma 23 Squamous Cell Carcinoma of Head and Neck 19 Liver Neoplasms 16 Head and Neck Neoplasms 14 Small Cell Lung Carcinoma 13 Sarcoma 12 Kidney Neoplasms 12 Glioma 11 Recurrence 9 Urinary Bladder Neoplasms 8 Gliosarcoma 7 Central Nervous System Neoplasms 7 Adenocarcinoma 7 Radiation Injuries 6 Prostate Cancer Metastatic 6 Ovarian Neoplasms 6 Neuroma, Acoustic 6 Meningioma 6

Interventions

lanreotide 3 Octreotide 3 pegvisomant 2 pasireotide 2 Cabergoline 2 Transcranial Magnetic Stimulation 1 Tissue Banks 1 Surgical Procedures, Operative 1 Solutions 1 Radiosurgery 1 Observation 1 Magnetic Resonance Spectroscopy 1 Injections 1 Dosage Forms 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03439709 2018-03-01

MERGE

Samsung Medical Center

Phase 3 Unknown

Acromegaly, Pituitary Neoplasms, Growth Hormone-Secreting Pituitary Adenoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡